Comparison of the efficacy and safety of ipratropium bromide (IB)/fenoterol hydrobromide (FEN) inhaled from a new soft mist inhaler (SMI) and from a conventional metered dose inhaler (MDI) in asthma patients - Berlin 2001

CDN Connection Issue

It appears that your current network does not allow connection to the CDN (Content Delivery Network) required for this service to function properly.

To resolve this issue, please try the following actions :

• Contact your network administrator : Inform them of this restriction so they can adjust the network settings accordingly.

• Use another network : Try connecting from a different network, such as another Wi-Fi network or a mobile connection.

We apologize for the inconvenience and thank you for your understanding.

International Congresses

Inhalation devices and technique

Chair(s): M. L. Levy (Kenton, UK), D. Price (Norwich, United Kingdom)

Session type: Thematic Poster Session

Comparison of the efficacy and safety of ipratropium bromide (IB)/fenoterol hydrobromide (FEN) inhaled from a new soft mist inhaler (SMI) and from a conventional metered dose inhaler (MDI) in asthma patients

W. Vincken, F. Gerken, D. M. Moonen, T. A. Banjte, J. J. Viljoen (Brussels, Belgium; Ingelheim am Rhein, Germany; EV Breda, The Netherlands; Bloemfontein, South Africa)

EVENTS HOME

Limited Access

Please log in to myERS to view this content.

Don't have a myERS account? Register

Note: consult the ERS Respiratory Channel access rights page for more details.

CDN Connection Issue

The ERS International Congress 2001, Berlin

Limited Access

#{title}